New drug applications for two presbyopia-correcting drops and surgical management options have led presbyopia coverage so far this year.
Read more stories below to mark Presbyopia Awareness Month:
Allergan submits NDA for presbyopia-correcting drop
Allergan has submitted a new drug application for its investigational presbyopia treatment and expects action on the NDA from the FDA by the end of the year. Read more.
FDA accepts IND for presbyopia drop
The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics. Read more.
BLOG: The